Dix Weaver received his BS (1972) and MS (1976) degrees from Purdue University. He continued his research in reproductive biochemistry and pesticide chemistry labs at Purdue. In 1981 he joined Eli Lilly and Company (Lilly) in biochemical toxicology and then managed ocular dermal toxicology labs. In 1990 Dix joined Lilly’s global chemical procurement team supporting new product development, launch, and commercialization until he retired from Lilly in 2009 when his Lilly site was sold to Evonik. He continued in the global chemical sourcing role with Evonik until retiring in 2013. He formed Weavchem LLC and continues to consult with pharma companies for sourcing of chemicals, intermediates, and API’s as well as contract negotiations.